Published by Iain Gilbert on 19th December 2024
(Sharecast News) - Life sciences group Aptamer has struck a new development contract agreement with a rare disease biopharmaceutical company worth up to £155,000.
URL: http://www.digitallook.com/dl/news/story/34767851/...